4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-053094
Chief Strategy Officer sold 1,862 shares at $7.17 ($13,351)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Nayak Sanjay · Chief Strategy Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-23 | Sale : show line 1 in the form 10b5-1 | −1,862 | $7.17 | $13,351 | 281,623 | D |
| Open-market sales · 1,862 sh · avg $7.17 · $13,351 | ||||||
Loading xslF345X05/tm2516174-4_4seq1.xml…